PE Anti-CD105 抗体 [MEM-229]
PE Anti-CD105 antibody [MEM-229]
Be the first to review this product! Submit a review
|
(28 Publications)
Anti-CD105 antibody [MEM-229] conjugated to PE - suitable for IHC-Fr, and reacts with pig samples. Clone [MEM-229] is a mouse monoclonal antibody cited in 64 publications.
別名を表示する
CD105, END, ENG, Endoglin
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - PE Anti-CD105 antibody [MEM-229] (AB53321)
ab53318 staining CD105 in infarcted porcine heart by Immunohistochemistry (Frozen sections). Cell nuclei were counterstained blue with DAPI.
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-CD105 antibody [MEM-229]
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Endoglin functions in the regulation of angiogenesis and vascular remodeling. It plays a significant role in mediating cellular responses to TGF-beta signaling influencing endothelial cell proliferation and migration. While not part of a larger structural complex endoglin interacts with receptors and signaling molecules important for vascular development and repair processes. This involvement aids in maintaining endothelial integrity and function under various physiological conditions.
Pathways
CD105 participates in the TGF-beta signaling and angiogenesis pathways. In these pathways it acts in conjunction with other proteins like TGF-beta receptors which play roles in cell differentiation proliferation and apoptosis. The interaction between CD105 and TGF-beta signaling regulates numerous cellular mechanisms impacting angiogenesis and cellular responses to environmental changes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (28)
Recent publications for all applications. Explore the full list and refine your search
Cells 14: PubMed40940806
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:434 PubMed39551765
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:162 PubMed38853239
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 13:e029880 PubMed38639336
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 14:49 PubMed36949528
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 19:491-502 PubMed36048327
2022
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 57:914-929.e7 PubMed35320732
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35328732
2022
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 35:2127-2134 PubMed34182488
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34073117
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com